|
DK319780A
(da)
*
|
1980-07-24 |
1982-01-25 |
Forenede Bryggerier As |
Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner
|
|
WO1983001074A1
(en)
*
|
1981-09-15 |
1983-03-31 |
Andresen, Finn, Hede |
Enzymatic preparation of human insulin or b-30 esters thereof
|
|
DK353781A
(da)
*
|
1981-08-10 |
1983-02-11 |
Novo Industri As |
Fremgangsmaade til fremstilling af insulinderivater
|
|
NL8201650A
(nl)
*
|
1982-04-21 |
1983-11-16 |
Akzo Nv |
Semisynthetische bereiding van humane insuline.
|
|
US4528134A
(en)
*
|
1982-12-27 |
1985-07-09 |
University Of Tn Research Corporation |
Method of separating A14 -125 I-insulin from heterogeneously labeled insulin molecules for biological studies
|
|
DK58285D0
(da)
*
|
1984-05-30 |
1985-02-08 |
Novo Industri As |
Peptider samt fremstilling og anvendelse deraf
|
|
PH25772A
(en)
*
|
1985-08-30 |
1991-10-18 |
Novo Industri As |
Insulin analogues, process for their preparation
|
|
DK257988D0
(da)
*
|
1988-05-11 |
1988-05-11 |
Novo Industri As |
Nye peptider
|
|
DE3844211A1
(de)
*
|
1988-12-29 |
1990-07-05 |
Hoechst Ag |
Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
|
|
DK134189D0
(da)
*
|
1989-03-20 |
1989-03-20 |
Nordisk Gentofte |
Insulinforbindelser
|
|
US5512459A
(en)
*
|
1993-07-20 |
1996-04-30 |
Bionebraska, Inc. |
Enzymatic method for modification or recombinant polypeptides
|
|
JP2001521004A
(ja)
|
1997-10-24 |
2001-11-06 |
イーライ・リリー・アンド・カンパニー |
脂肪酸−アシル化インスリン類似体
|
|
CO4970787A1
(es)
*
|
1997-12-23 |
2000-11-07 |
Lilly Co Eli |
Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
|
|
CA2392844A1
(en)
|
1999-12-29 |
2001-07-12 |
Novo Nordisk A/S |
Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
|
|
AR025646A1
(es)
*
|
2000-09-13 |
2002-12-04 |
Beta Lab Sa |
Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
|
|
US7396903B2
(en)
*
|
2001-11-19 |
2008-07-08 |
Novo Nordisk A/S |
Process for preparing insulin compounds
|
|
JP4404631B2
(ja)
|
2001-11-19 |
2010-01-27 |
ノボ ノルディスク アクティーゼルスカブ |
インスリン化合物の製造方法
|
|
UA46667C2
(en)
*
|
2001-12-29 |
2006-01-16 |
Omakooe Ltd Liability Company |
Method for preparing semisynthetic human insulin
|
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
|
PT2319500E
(pt)
*
|
2004-03-12 |
2013-01-23 |
Biodel Inc |
Composições de distribuição de fármacos de actuação rápida
|
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
|
DK1881850T3
(da)
|
2005-05-13 |
2011-01-03 |
Lilly Co Eli |
GLP-1-PEGylerede forbindelser
|
|
ES2361166T3
(es)
*
|
2005-07-08 |
2011-06-14 |
Biocon Limited |
Conjugados de insulina.
|
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
|
US7713929B2
(en)
*
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
|
EP2012817A2
(en)
*
|
2006-04-12 |
2009-01-14 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
|
EP2574624A1
(en)
|
2006-04-20 |
2013-04-03 |
Amgen Inc. |
GLP-1 compounds
|
|
WO2008124522A2
(en)
*
|
2007-04-04 |
2008-10-16 |
Biodel, Inc. |
Amylin formulations
|
|
EP2234644B1
(en)
*
|
2008-01-04 |
2013-07-31 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
|
HRP20170319T1
(hr)
|
2008-07-30 |
2017-05-05 |
Takeda Pharmaceutical Company Limited |
Derivat metastina i njegova uporaba
|
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
|
WO2011031662A1
(en)
|
2009-09-08 |
2011-03-17 |
Kent Stephen B H |
Ester insulin
|
|
JP5973427B2
(ja)
|
2010-06-23 |
2016-08-23 |
ノヴォ ノルディスク アー/エス |
追加のジスルフィド結合を含有するインスリン類似体
|
|
CN104693302A
(zh)
|
2010-06-23 |
2015-06-10 |
诺沃—诺迪斯克有限公司 |
包含额外的二硫键的胰岛素衍生物
|
|
EP2585483A1
(en)
|
2010-06-23 |
2013-05-01 |
Novo Nordisk A/S |
Human insulin containing additional disulfide bonds
|
|
WO2012123519A2
(en)
|
2011-03-15 |
2012-09-20 |
Novo Nordisk A/S |
Human insulin analogues and derivatives comprising cysteine substitutions
|
|
WO2012171994A1
(en)
|
2011-06-15 |
2012-12-20 |
Novo Nordisk A/S |
Multi substituted insulins
|
|
JP6735561B2
(ja)
|
2012-12-03 |
2020-08-05 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
O−グリコシル化カルボキシ末端部分(ctp)ペプチド系のインスリンおよびインスリン類似体
|
|
EP3004156A1
(en)
|
2013-06-07 |
2016-04-13 |
Novo Nordisk A/S |
Method for making mature insulin polypeptides
|
|
CN105849273B
(zh)
*
|
2013-12-23 |
2020-01-14 |
拜康研究有限公司 |
人胰岛素甲酯的生产方法
|
|
SG11202001077UA
(en)
|
2017-08-17 |
2020-03-30 |
Novo Nordisk As |
Novel acylated insulin analogues and uses thereof
|
|
WO2023144240A1
(en)
|
2022-01-26 |
2023-08-03 |
Novo Nordisk Research Centre Oxford Limited |
Glucose sensitive insulin derivatives and uses thereof
|